 39849
.U
87071359
.S
Urology 8703; 28(5):404-8
.M
Adenocarcinoma/*DT/MO; Antineoplastic Agents, Combined/*TU; Clinical Trials; Comparative Study; Cyclophosphamide/AD; Fluorouracil/AD; Human; Male; Melphalan/AD; Methotrexate/AD; Prednisone/AD; Prostatic Neoplasms/*DT/MO; Random Allocation; Vincristine/AD.
.T
Value of cyclophosphamide or melphalan as combined chemotherapy in hormonally unresponsive prostatic carcinoma.
.P
CLINICAL TRIAL; JOURNAL ARTICLE.
.W
This prospective randomized study in nonhormonally responsive adenocarcinoma of the prostate shows that response rates to melphalan vs cyclophosphamide groups were virtually identical.
.A
Graham SD; Walker A; Cox EB; Laszlo J; Berry WR; Paulson DF.
